
Galmed Pharmaceuticals Ltd. GLMD
$ 2.61
-4.74%
Annual report 2023
added 02-15-2025
Country |
![]() |
IPO year |
2014 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
2.77 M |
Market Cap[1] |
$ 7.23 M |
EBITDA (LTM) |
$ -10.5 M |
P/E (LTM) |
0.51 |
P/S (LTM) |
23.33 |
EPS (LTM) |
0.98 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.